Literature DB >> 32651465

Harder, better, faster.

Danielle Schultz1, Louis-Charles Campeau2.   

Abstract

Year:  2020        PMID： 32651465     DOI： 10.1038/s41557-020-0510-8

Source DB:  PubMed          Journal:  Nat Chem        ISSN： 1755-4330            Impact factor:   24.427


× No keyword cloud information.
  1 in total

1.  CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target.

Authors:  Tomas Friman; Alexey Chernobrovkin; Daniel Martinez Molina; Laurence Arnold
Journal:  SLAS Discov       Date:  2020-11-18       Impact factor: 3.341
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.